Clinical trial
The Clinical Efficiency of Transcriptome-based Endometrial Receptivity Assessment (Tb-ERA) in Chinese Patients With Recurrent Implantation Failure (RIF)
NCT04497558 is registered in ClinicalTrials.gov with ShangHai Ji Ai Genetics & IVF Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Clinical Efficiency of Transcriptome-based Endometrial Receptivity Assessment (Tb-ERA) in Chinese Patients With Recurrent Implantation Failure (RIF)
- Lead sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 20, 2020
- Completion date
- December 30, 2024
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial receptivity, repeated implantation failure